These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria. Gatliff J; Campanella M Biochem J; 2016 Jan; 473(2):107-21. PubMed ID: 26733718 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol and the interaction of proteins with membrane domains. Epand RM Prog Lipid Res; 2006 Jul; 45(4):279-94. PubMed ID: 16574236 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells. Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920 [TBL] [Abstract][Full Text] [Related]
11. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands. Taliani S; Pugliesi I; Da Settimo F Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial translocator protein (TSPO): From physiology to cardioprotection. Morin D; Musman J; Pons S; Berdeaux A; Ghaleh B Biochem Pharmacol; 2016 Apr; 105():1-13. PubMed ID: 26688086 [TBL] [Abstract][Full Text] [Related]
13. The changing landscape in translocator protein (TSPO) function. Selvaraj V; Stocco DM Trends Endocrinol Metab; 2015 Jul; 26(7):341-8. PubMed ID: 25801473 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Li H; Yao Z; Degenhardt B; Teper G; Papadopoulos V Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1267-72. PubMed ID: 11158628 [TBL] [Abstract][Full Text] [Related]
15. Targeting mitochondrial energy metabolism with TSPO ligands. Gut P Biochem Soc Trans; 2015 Aug; 43(4):537-42. PubMed ID: 26551690 [TBL] [Abstract][Full Text] [Related]
16. The translocator protein (TSPO): a novel target for cancer chemotherapy. Austin CJ; Kahlert J; Kassiou M; Rendina LM Int J Biochem Cell Biol; 2013 Jul; 45(7):1212-6. PubMed ID: 23518318 [TBL] [Abstract][Full Text] [Related]
17. Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. Liu J; Rone MB; Papadopoulos V J Biol Chem; 2006 Dec; 281(50):38879-93. PubMed ID: 17050526 [TBL] [Abstract][Full Text] [Related]
18. Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding. Murail S; Robert JC; Coïc YM; Neumann JM; Ostuni MA; Yao ZX; Papadopoulos V; Jamin N; Lacapère JJ Biochim Biophys Acta; 2008 Jun; 1778(6):1375-81. PubMed ID: 18420025 [TBL] [Abstract][Full Text] [Related]
19. Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine. Ostuni MA; Péranzi G; Ducroc RA; Fasseu M; Vidic B; Dumont J; Papadopoulos V; Lacapere JJ Biol Cell; 2009 Jul; 101(10):573-86. PubMed ID: 19392661 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Rone MB; Fan J; Papadopoulos V Biochim Biophys Acta; 2009 Jul; 1791(7):646-58. PubMed ID: 19286473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]